Godavari Biorefineries Ltd
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
- Market Cap ₹ 1,163 Cr.
- Current Price ₹ 227
- High / Low ₹ 354 / 224
- Stock P/E 45.6
- Book Value ₹ 151
- Dividend Yield 0.00 %
- ROCE 6.22 %
- ROE 3.95 %
- Face Value ₹ 10.0
Pros
- Debtor days have improved from 28.1 to 19.3 days.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 5.18% over past five years.
- Company has a low return on equity of 2.03% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 1,449 | 1,526 | 1,691 | 2,000 | 1,675 | 1,853 | 1,965 | 1,983 | |
| 1,347 | 1,372 | 1,560 | 1,861 | 1,544 | 1,753 | 1,840 | 1,866 | |
| Operating Profit | 102 | 155 | 131 | 139 | 132 | 100 | 125 | 117 |
| OPM % | 7% | 10% | 8% | 7% | 8% | 5% | 6% | 6% |
| 13 | 7 | 6 | 6 | 14 | 16 | -21 | -18 | |
| Interest | 68 | 72 | 60 | 73 | 76 | 72 | 48 | 47 |
| Depreciation | 45 | 47 | 48 | 50 | 60 | 50 | 54 | 55 |
| Profit before tax | 2 | 43 | 29 | 23 | 10 | -5 | 2 | -4 |
| Tax % | -53% | 43% | 44% | 49% | -2% | -51% | 20% | |
| 3 | 25 | 16 | 12 | 11 | -3 | 1 | -3 | |
| EPS in Rs | 0.60 | 5.86 | 3.89 | 2.86 | 2.52 | -0.52 | 0.24 | -0.67 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | -1% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 5% |
| 3 Years: | 35% |
| TTM: | 251% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | 2% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 42 | 42 | 42 | 42 | 42 | 51 | 51 |
| Reserves | 392 | 416 | 432 | 442 | 452 | 721 | 722 |
| 584 | 564 | 634 | 739 | 655 | 488 | 525 | |
| 419 | 417 | 625 | 517 | 838 | 683 | 730 | |
| Total Liabilities | 1,437 | 1,440 | 1,734 | 1,740 | 1,987 | 1,944 | 2,028 |
| 733 | 706 | 666 | 866 | 849 | 862 | 865 | |
| CWIP | 17 | 9 | 50 | 17 | 29 | 38 | 148 |
| Investments | 14 | 14 | 14 | 16 | 16 | 16 | 16 |
| 673 | 711 | 1,004 | 842 | 1,093 | 1,028 | 999 | |
| Total Assets | 1,437 | 1,440 | 1,734 | 1,740 | 1,987 | 1,944 | 2,028 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| 240 | 129 | 40 | 185 | 196 | -1 | 173 | |
| -28 | -8 | -47 | -217 | -45 | -61 | -163 | |
| -211 | -120 | 7 | 31 | -151 | 63 | -10 | |
| Net Cash Flow | 0 | 0 | 1 | -1 | 1 | 0 | 1 |
| Free Cash Flow | 209 | 118 | -9 | -32 | 141 | -73 | 8 |
| CFO/OP | 236% | 83% | 32% | 134% | 150% | 4% | 139% |
Ratios
Standalone / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 30 | 39 | 38 | 39 | 40 | 26 | 19 |
| Inventory Days | 131 | 147 | 250 | 194 | 196 | ||
| Days Payable | 124 | 133 | 197 | 141 | 147 | ||
| Cash Conversion Cycle | 37 | 53 | 38 | 39 | 92 | 79 | 69 |
| Working Capital Days | -69 | 0 | 4 | 3 | -17 | 19 | 12 |
| ROCE % | 11% | 8% | 8% | 7% | 6% | 6% |
Insights
In beta| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cane Crushing Volume Lakh Metric Tonnes |
|
|||||||
| Distillery Capacity KLPD |
||||||||
| Sugar Recovery Rate % |
||||||||
| Specialty Chemicals Share of Bio-Based Chemicals Revenue % |
||||||||
| Sugar Crushing Capacity TCD |
||||||||
| Ethanol Sales Volume KL |
||||||||
| Jivana Retail Store Count number |
||||||||
| Sugar Production Volume MT |
||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper publication on circular in the form of advertisement to invite public deposit
-
Announcement Under Regulation 30- Patent
- Mexican Patent Office granted patent for compounds treating viral infections on October 2, 2026.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Announcement under Regulation 30 (LODR)-Change in Management
- AGM approved director reappointments and appointments, including MD Samir Somaiya effective 1 April 2027.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- Godavari Biorefineries held its 71st AGM on 28 Sep 2026; voting results to be announced later.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from web
-
Annual Report 2023
from web
-
Annual Report 2022
from web
-
Annual Report 2021
from web
-
Annual Report 2020
from web
Concalls
-
Aug 2026PPT REC
-
Jun 2026Transcript PPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT REC
-
May 2025PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Business Overview:[1][2]
a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities.
b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power
c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India
d) Company is the largest Manufacturer of MPO in India in terms of installed capacity
e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally
f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.